Summary. An alteration of an amino acid sequence in the processing site of the insulin proreceptor by a point mutation of the insulin receptor gene produced extreme insulin resistance. We characterized functional properties of the unprocessed insulin receptor in transformed lymphocytes from a patient. Insulin binding to intact cells and to a partially purified insulin receptor preparation was radically decreased to 20% and 18% of the control values, respectively. In competitive insulin bind-
tance, transformed lymphocytes, point mutation.
Insulin initiates its cellular response by binding to the insulin receptor [1, 2] . Thus, a primary defect in insulin receptors leads to extreme insulin resistance as demonstrated in type A insulin resistance [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] , leprechaunism [4, 6, 7, 11, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] , and Rabson-Mendenhall syndrome [14, [25] [26] [27] . Recently, we [28, 29] and Kakehi et al. [30] reported a patient with type A extreme insulin resistance due to abnormal processing of the insulin proreceptor. Subsequently, DNA sequencing of the interconnecting region between alpha-and beta-subunits revealed G-+T point mutation which changed -Arg-LysArg-Arg-to -Arg-Lys-Arg-Ser- [31, 32] . The Arg---+Ser structural change appeared to be the cause for abnormal processing of the insulin proreceptor. However, attention has been focused on the mechanism of abnormal processing of the proreceptor in the previous studies [28] [29] [30] [31] [32] , and functional properties of the unprocessed insulin proreceptor itself have not been investigated in detail. Since insulin binding was markedly decreased, hormone binding specificity and intramolecular signal transmission may also undergo a change by structural alteration due to abnormal processing of the insulin proreceptor.
Therefore, in the present study, we attempted to characterize the structural alteration of binding sites of the unprocessed insulin proreceptor by examining the binding properties by using various insulin analogues in intact cells and partially lectin-purified insulin receptor preparations. Furthermore, we examined whether selfassociation of the receptors into the oligomeric structure occurred in the proreceptor. Finally, we investigated kinase activity of the proreceptor to study whether the structural change could alter intramolecular signal transmission between alpha-and beta-subunits.
Subjects and methods
Two sisters, 27 (patient 1) and 23 (patient 2) years old, were products of consanguineous marriage (nephew-niece) and had been born after full-term uncomplicated pregnancy and delivery. Birth weights were 1,800 g (patient 1) and 1,750 g (patient 2). At birth, they were noted to be hirsute. Their growth has been retarded since infancy. At the age of 10 (patient 1) and 6 (patient2) years, they were diagnosed with diabetes mellitus. Current status included presentation with primary amenorrhea for both women. Patient 2 had suffered from bronchial asthma and had been treated with steroids since three months of age, but past history was otherwise unremarkable. There was no history of diabetes mellitus in other family members. On physical examination, patient 1 was 128 cm tall and weighed 35 kg, and patient 2 was 133 cm tall and weighed 36 kg. They had apathetic faces, saddle noses, odontodysplasia, abdominal distention, generalized hirsutism, and acanthosis nigricans in the neck and the axillae. Their external genital were normal. They had mental retardation marked in patient 1 and mild in patient 2. Ophthalmoscopic examination revealed proliferative retinopathy with retinal detachment in patient 1 and background retinopathy in patient 2. Routine laboratory tests at the time of admission were normal except for glucose metabolism. Oral glucose tolerance tests revealed diabetic patterns in both patients. Fasting blood glucose levels ranged from 7.0 to 12.0 mmol/1 in patient i and from 4.6 to 7.2 mmol/1 in patient 2. Serum insulin levels were 286-351 ~tU/ml in patient 1 and 242-312 ~tU/ml in patient 2 at fasting, and 978 ~tU/ml in patient 1 and 1421 ~tU/ml in patient 2 at maximum. An i.v. bolus of exogenous insulin (0.1 U/kg) decreased initial blood glucose levels by 18 and 15% at 60 rain after injection. Neither anti-insulin nor anti-insulin receptor antibody was detectable. Urinary glucose was between 77-100 g/day in patient 1 and was not detected in patient 2. Endocrine studies revealed normal values of plasma growth hormone, thyroid stimulating hormone, T3, T4, cortisol, and glucagon in both the patients. In spite of normal estradiol and estriol levels in both patients estrone levels were elevated to 65.5 and 159pg/ml (normal, 10-60 pg/ml), respectively. Testosterone and androstenedione levels were within normal range in patient I and were elevated to 2.9 ng/ml (normal, 0.66-1.95 ng/ml) and 5.3 ng/ml (normal, 0.5-2.4 ng/ml) in patient 2. Serum luteinizing hormone (LH) and follicular stimulating hormone (FSH) levels responded normally to lnteiniziug hormone releasing hormone stimulation in patient 1. However, stimulated LH level was high, and the response of FSH was normal in patient 2. CT scan and ultrasonography revealed normal findings in patient 1, but showed the bilateral polycysfic ovary in patient 2. Patient i was treated with metformin and glibenclamide, and HbA1 improved from 10.1 to 8.6%. Glucose control in patient 2 was relatively good with diet only. Insulin binding to their erythrocytes was decreased to 26 and 32% of control value, respectively, as previously described [28] , and insulin binding to erythrocytes from their mother also mildly decreased to 68%. The details of glucose and insulin levels of the parents was not available because of their lack of cooperation in the study. The informed consent for this study was obtained from the patients, and our
Iodination of insulin
125I-insulin was prepared by the method of Freychet et al. [2] using chloramine T to a specific activity of 70-120 lxCi/ug. Subsequently, the iodinated insulin was purified by Biogel P-30 (Biorad Laboratories. Richmond, Calif, USA).
Transformed lymphocytes culture
Epstein-Barr virus transformed lymphocyte cell lines, established from peripheral blood lymphocytes as described previously from the patients and six normal subjects, were grown in RPMI 1640 medium supplemented with 10% FBS [27] . Since two cell lines from the sisters showed extremely low insulin binding [28] , the following characterization of the insulin receptor was performed only in the cells from patient 2.
Insulin binding to intact cells
125I-insulin binding to transformed lymphocytes has been described elsewhere [4] . Binding studies were carried out at 15 ~ C for 3.5 h. In all binding studies, non-specific binding was less than 12% of the total bound, and degradation of 125I-insulin in the buffer was assessed by precipitation with 7.5% trichloroacetic acid (TCA), and was less than 7%.
Preparation of partially purified insulin receptor
Transformed lymphocytes (> 5 x 108 cells) were washed with phosphate-buffered saline (PBS) and solubilized in a solution of 50 retool/1 Hepes buffer containing 1% Triton X-100, 2 mmol phenylmethyl sulfonyl fluoride, and 1 ~tg/ml aprotinin, pH 7.6. The cell extract was then stirred at 4 ~ C for 60 min. After removing insoluble material by centrifugation at 200,000 • g for 60 min, supernatants were applied to a WGA-agarose column. After extensive washing with a buffer containing 50 mmol/1 Hepes, 150 mmol/1 NaC1, and 0.t% Triton X-100, pH 7.4, glycoprotein-enriched preparations were eluted by a buffer containing 0.3 mnol/1 N-Acetyl-D-glucosamine in 50 mmol/1 Hepes, 150 mmol/1 NaC1, and 0.1% Triton X-100, pH 7.6 [10] .
Insulin binding to lectin-purified insulin receptor preparations
Lectin-purified receptors were incubated with 125I-insulin (0.4 ng/ml) and various concentrations of unlabelled peptides at 4~ for 16 h. Bound insulin was separated from the free insulin by precipitation with polyethylene glycol at a final concentration of 12.5%, using 0.1 mg/ml of bovine gamma-globulins as carrier.
Affinity cross-linking studies
Affinity labelling was performed by previously published methods with some modifications [37] . The lectin-purified extracts were incubated with 125I-insulin (1 ng/ml) in a buffer containing 120 mmol/1 NaC1, 2.5 mmol/1 KC1, 1.2 mmol/1 MgSO4, 15 mmol/1 Na-acetate, 10mmol/l glucose, 1 mmol~/1 EDTA, 50mmol/1 Hepes, and 1% BSA, pH 7.8, at 4~ for 16 h, and cross-linked with 0.1 mmol/1 DSS. After incubation at 4~ for 20 min, the cross-linking reaction was stopped by the addition of Tris (10 mmol/1)/EDTA (1 mmol/1) in PBS.
Autophosphorylation assays
The lectin-purified extracts were preincubated with various concentrations of insulin at 4~ for 16h. The phosphorylation reaction was initiated by adding a solution composed of 20 mmol/1 Mn acetate, 5 mmol/1 cytidine triphosphate, 20 lxmol/1 ATP, and 30 gCi of [gamma-32p]ATP. After incubation at 4~ for 10 min, the reaction was terminated by adding stopping solution containing 0.2% Triton X-100, 10 mmol/1 EDTA, 100 mmol/1 NaF, 20 mmol/1 sodium pyrophosphate, 20 mmol/1 ATP, and 20mmol/1 Hepes, pH 7.6 [10] .
Immunoprecipitation of insulin receptors
Receptors were incubated for 16 h at 4~ with anti-insulin receptor serum or normal human serum. Immune complexes were precipitated by addition of a 10% suspension of Pansorbin. After incubation for 2 h at 4 ~ C, the immune complexes bound to Pansorbin were sedimented by centrifugation at 10,000 x g for 10 min. After washing, the pellet was dissolved in the Laemmli buffer containing 2% sodium dodecyl sulfate (SDS), 10% glycerol, 0.01% bromophenol blue, and 10 mmol/1 sodium phosphate with or without 100 mmol/1 dithiothreitol (DTI') and boiled for 5 min and used for SDS-polyacrylamide gel electrophoresis (SDS-PAGE) [10] . 
Results

Electrophoresis
Electrophoretic separation of the labelled components in 7.5% or 4-12 linear gradient polyacrylamide gels was performed as previously described [38] . The phosphorylated proteins were detected by autoradiography of the stained and dried gels on Kodak X-Omat AR film (Kodak Co. Tokyo, Japan) with intensifying screen. The specific bands were excised from the gel and the radioactivity was quantitated by liquid scintillation counting.
Statistical analysis
Statistical analysis was performed using the Student's t-test to analyse the significant differences.
Insulin binding to transformed lymphocytes
Insulin binding to transformed lymphocytes from the patient was markedly decreased to 20% of that of normal control subjects. Scatchard analysis revealed that low insulin binding in the patient was due to decreased affinity and that receptor number was not decreased (Fig. 1) .
Competitive binding ability of proinsulin and IGF-I in intact cells
To characterize insulin binding to the unprocessed insulin proreceptor, various insulin analogues were tested in binding studies. Figure 2 shows the competitive bind- Hormone Concentration ( ng/ml )
EDso and relative binding ability of insulin analogues
To clarify the competitive ability of various insulin analogues tested for binding, study, EDs0 for each of the analogues was calculated (Table1).
[LeuA3] -, [LeuB24] -, [SerB24]-insulin, and mini-proinsulin showed almost the same EDs0 in both the patient and control subject. However, the higher concentration of proinsulin and IGF-I was required for half rrmximal inhibition of 125I-insulin binding in the patient compared to that in the control subjects. Therefore, the larger insulin analogues with connecting peptides, i.e. proinsulin and IGF-I showed low competitive binding ability in the patient cells. Hormone Goncentration ( ng/ml ) ing studies of proinsulin and IGF-I. In transformed lymphocytes from normal subjects, the competitive ability to bind to receptors are 2.20% and 0.28% of normal insulin, respectively. In transformed lymphocytes from the patient, however, the competitive ability of proinsulin and IGF-I to bind to receptors was markedly decreased to 0.38% and 0.04% of normal insulin. The unprocessed insulin proreceptor was cleaved by trypsin treatment resulting in normal insulin binding. The markedly low comparative binding abilities of proinsulin and IGF-I were also restored to normal by trypsin treatment as shown in Figure 2 .
Competitive binding ability of insulin analogues in lectin-purified insulin receptor preparations
Competitive binding ability of insulin analogues was studied in solubilized receptors to examine whether the abnormal binding characteristics of proinsulin and IGF-I were retained in the proreceptor freed from plasma membranes. Insulin binding to partially purified receptor preparations was also decreased to 18% of the control value in the patient. We performed competitive binding studies of proinsulin, IGF-I, and [LeuB24]-insulin in partially lectin-purified receptor preparations. In the preparations from normal transformed lymphocytes, the competitive ability to bind to receptors was 2.50%, 0.20%, and 16.7% of normal insulin, respectively. In the preparations from the patient's transformed lymphocytes, the competitive ability of proinsulin and IGF-I to bind to receptors was also the same, i.e. 2.20%, 0.20%, and 18.8%, respectively. This finding was in contrast to the results of binding studies in intact cells. Thus, abnormal binding characteristics were only shown in intact cells from the patient.
Autophosphorylation of insulin receptor in transformed lymphocytes
Insulin receptors from transformed lymphocytes were partially purified with WGA-agarose and autophosphorylation of the beta subunit was determined. Insulin stimulated the incorporation of 32phosphorus (32p) into
Competitive binding ability of mutant insulins in intact cells
Various mutant insulins were tested for binding to the proreceptor in order to study whether markedly reduced competitive binding ability was limited to proinsulin and IGF-I. As shown in Figure 3 , the competitive binding ability of [LeuA3] -, [Leu B24]_, [SerB24]_insulin, and mini-proinsulin on 125I-insulin binding to transformed lymphocytes was the same between the patient and control subjects. Values are in ng/ml (means _+ SEM). a p< 0.01 vs. control subjects 4) . Then, the samples were immunoprecipitated with anti-insulin receptor antibody, and subjected to SDS-PAGE on a 4-12% linear gradient gel under nonreducing condition as described in Methods the 95 kilodalton kDa protein beta-subunit of normal cells in a dose-dependent manner. Insulin maximally increased the incorporation to 450% above basal incorporation. However, in the cells from the patient, 32p was incorporated into a 210kDa protein as shown in Figure 4 -A. Although the maximally stimulated incorporation to the 210 kDa protein was 430% above basal incorporation, the net incorporation ofa2p per mg of receptor protein was decreased to 20% of that of the normal cells. Therefore, when the percent insulin-stimulated autophosphorylation over basal was plotted as a function of insulin binding activity in the partially purified preparation with WGA-agarose, there was no difference between the patient and the control subject. To examine whether phosphorylation of 95 kDa cleaved products can b e stimulated by insulin, we performed autophosphorylation on solubilized insulin receptors after 0.025% trypsin treatment. As shown in Figure 4 -B, 32p was incorporated into a 95 kDa protein, and insulin stimulated the incorporation in a dose-dependent manner.
Affinity cross-linking under unreduced conditions
To examine whether oligomerization and formation of disulfide bonds occurred in the unprocessed insulin proreceptors, the proreceptor was cross-linked and electrophoresed under non-reducing conditions. Disulfidelinked oligomers, probably tetramers, were normally formed in the patient (Fig. 5) . Thus, the heterodimeric formation and subsequent glycosylation appeared to be normal and these abnormal proreceptors were normally transported to the plasma membrane.
Discussion
Ourselves [28, 39, 31] and others [30, 32] have reported the same cases with insulin proreceptors, the differences being in the degree of decreased insulin binding to the proreceptor in transformed lymphocytes. Our studies showed 80% reduction, but Kakehi et al. reported the marked reduction to about one fifteenth of control value [30] . Although the cause of the discrepancy was unknown, slightly increased insulin binding ability of the proreceptor allowed us to analyse the functional properties of the insulin proreceptor. Decreased insulin binding appeared to be due to decreased affinity in transformed lymphocytes from the patient. The normalized insulin binding and autophosphorylation after trypsin treatment on that proreceptor supported the notion of decreased affinity of proreceptor rather than that of decreased numbers of the receptors. The unprocessed insulin proreceptor showed decreased affinity to insulin, indicating that lack of cleavage between the alpha and beta subunit changed the three dimensional structure making binding sites less accessible to insulin. The proreceptor showed not only decreased affinity but also uniclue binding characteristics, namely comparatively low affinity to proinsulin and IGF-I. Whereas relative binding affinity of insulin analogues with substitution of one amino residue was normal, that of proinsulin and IGF-I was markedly decreased. These findings suggest that the C-peptide portion may interfere with the interaction between the proreceptor and proinsulin or IGF-I, probably by a steric hindrance effect of C-peptide residues. However, mini-proinsulin behaved normally in binding to the proreceptor, which indicated that insulins with a shorter length of C-peptide or simply insulins with a smaller size showed relatively undisturbed binding ability. The abnormal binding properties of the proreceptor were shown in whole cells, but not in partially lectin-purified insulin receptor preparations. Although, the possibility of mild hydrolysis affecting binding characteristics during the process of the disruption of the cells and preparation of the receptor cannot be completely ruled out, the finding suggests that the characteristic alteration of three-dimensional receptor structure does not survive after solubilization of insulin receptors.
The structural change of the proreceptor resulted in abnormal insulin binding, i. e. three dimensional change in binding sites. The question of how intramolecular signal transmission occurs in the proreceptor can be answered by the study of autophosphorylation. In the proreceptor, decreased autophosphorylation was proportional to the amount of insulin bound. Therefore, the signal elicited by insulin binding to the alpha subunit was transmitted normally to the beta subunit of the uncleaved insulin proreceptor. Kakehi et al. reported that the insulin-stimulated dose response curve of autophosphorylation of the proreceptor appeared to be shifted to the fight [30] . However, because insulin binding was very low, this report may be difficult to interpret. The chimera receptor consisting of an intracellular portion of the epidermal growth factor (EGF) receptor and an extracellular portion of the insulin receptor possesses the ability to transmit the signal of insulin binding to elicit kinase activity of intracellular EGF receptors [39] . However, the chimera receptor consisting of an extracellular portion of the interleukin-2 receptor and an intracellular portion of the insulin receptor fails to show intramolecular signal transmission, i.e. failure of activation of kinase with interleukin-2 binding [40] . These results suggest that moderate modification of alpha-and beta-subunit interaction does not disturb the signal transmission from the binding site to kinase domain.
The mature insulin receptor is composed of two alpha-and beta-subunits linked by disulfide bonds. Since the receptor oligomerization occurs during posttranslational processing [41] , changes in the tertiary structure of the proreceptor monomer may disturb dimerization, and it may be functionally relevant whether dimerization occurred in the unprocessed insulin proreceptor. The present study demonstrated that dimerization of the proreceptor occurred similarly to normal insulin receptors. Therefore, cleavage of the insulin proreceptor did not appear to be necessary to dimerize. This finding is consistent with the report that normal insulin proreceptors are able to dimerize during posttranslational processing of the insulin receptor [41] . Thus, decreased insulin binding appeared not to be associated with abnormal dimerization.
In summary, conformational alteration of the unprocessed insulin proreceptor showed unique characteristics of insulin binding, i.e. markedly low affinity to IGF-I and proinsulin compared to other analogues without C-peptide. In spite of abnormal binding specificity, the binding signal was normally transmitted to the beta-subunit of the proreceptor. These results suggest that the proreceptor embedded in the plasma membranes shows a different conformational structure of the insulin binding site compared with the solubilized receptor, and that intramolecular signal transmission through the proreceptor was normal.
